Feb 21: 7 Strong Themes — Auto Parts, Gene Therapy & Genomics
7 strong themes — 1 running · 6 recurred. Top: Auto Parts +9.3%.
Strong themes7
Top change+9.3%
LeaderMotivelink
Average change by strong theme
Average change of member stocks, by theme · descending
Theme leaders · recent trend
The line is the trend; the end-point colour is the last trading day's direction. Stocks without enough price history show as -
| Theme | Leader | Change | Trend |
|---|---|---|---|
| Auto Parts | Motivelink | +19.25% | - |
| Gene Therapy & Genomics | ViGenCell | +19.03% | |
| Steel Majors | Posco Steeleon | +21.41% | |
| Cancer Immunotherapy | ViGenCell | +19.03% | |
| Stem Cells | ENCell | +14.36% | |
| Steel (Small & Mid Cap) | Moonbae Steel | +8.22% | |
| Car Majors | Hanon Systems | +2.39% |
On 2025-02-21, all seven strong themes closed with every listed stock higher. Auto Parts led with an average change of 9.33%, and all 10 of its stocks rose.
Motivelink topped Auto Parts at 19.25%, with SL at 18.23% and Korea Movenex at 15.29%. News on Feb 21 described Motivelink as strong on its second day of listing.
Gene Therapy & Genomics returned after a 164-day gap with an average change of 7.36%. ViGenCell led at 19.03% and also topped Cancer Immunotherapy, which averaged 5.62%.
Today’s Strong Themes at a Glance
| # | Theme | Status | Avg. change | Up/Total | Leader |
|---|---|---|---|---|---|
| 1 | Auto Parts | recurred after 2 days | +9.3% | 10/10 | Motivelink |
| 2 | Gene Therapy & Genomics | recurred after 164 days | +7.4% | 10/10 | ViGenCell |
| 3 | Steel Majors | 3 days running | +6.0% | 9/9 | Posco Steeleon |
| 4 | Cancer Immunotherapy | recurred after 53 days | +5.6% | 10/10 | ViGenCell |
| 5 | Stem Cells | recurred after 71 days | +4.4% | 9/9 | ENCell |
| 6 | Steel (Small & Mid Cap) | recurred after 2 days | +3.9% | 10/10 | Moonbae Steel |
| 7 | Car Majors | recurred after 2 days | +1.6% | 5/5 | Hanon Systems |
Theme by Theme
1. Auto Parts (recurred after 2 days)
- Episode: started 2025-02-21, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
Motivelink 463480 | +19.2% | 21,000 | ★ |
SL 005850 | +18.2% | 34,700 | |
Korea Movenex 010100 | +15.3% | 5,390 | |
SNT Dynamics 003570 | +8.2% | 31,850 | |
Edge Foundry 105550 | +6.7% | 4,935 | |
Daeho Al 069460 | +5.8% | 1,350 | |
Hyundai Industrial 170030 | +5.6% | 5,320 | |
Sungwoo 458650 | +5.3% | 17,640 | |
Hwashin 010690 | +4.8% | 7,450 | |
A-jin Industry 013310 | +4.2% | 2,715 |
Related news
- 모티브링크, 코스닥 상장 첫날 ‘따블’…193% 급등[줍줍리포트] — 서울경제 (Korean)
- 코스닥 새내기株 모티브링크 상장 첫날 170% 급등[줍줍리포트] — 서울경제 (Korean)
- [특징주]모티브링크, 상장 이틀째 강세…장중 한 때 상한가 — 머니투데이 (Korean)
2. Gene Therapy & Genomics (recurred after 164 days)
- Episode: started 2025-02-21, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
ViGenCell 308080 | +19.0% | 2,940 | ★ |
ENCell 456070 | +14.4% | 20,700 | |
Olipass 244460 | +9.2% | 2,320 | |
Genome&Company 314130 | +8.6% | 2,905 | |
Gencurix 229000 | +8.1% | 2,085 | |
Xcell Therapeutics 373110 | +6.3% | 5,150 | |
Genomictree 228760 | +3.4% | 18,240 | |
Theragen Etex 066700 | +1.8% | 3,120 | |
GC Biopharma 006280 | +1.4% | 133,300 | |
Psomagen 950200 | +1.4% | 4,045 |
3. Steel Majors (3 days running)
- Episode: started 2025-02-19, day 3
| Stock | Change | Close | Leader |
|---|---|---|---|
Posco Steeleon 058430 | +21.4% | 41,400 | ★ |
Dongkuk Steel Mill 460860 | +12.2% | 9,640 | |
POSCO Holdings 005490 | +5.0% | 282,000 | |
SeAH Steel 306200 | +4.2% | 155,700 | |
Hyundai Steel Company 004020 | +3.5% | 26,450 | |
Kisco 104700 | +3.3% | 8,110 | |
KG Dongbusteel 016380 | +1.9% | 6,260 | |
Daehan Steel 084010 | +1.3% | 15,500 | |
SeAH Besteel Holdings 001430 | +0.9% | 19,840 |
4. Cancer Immunotherapy (recurred after 53 days)
- Episode: started 2025-02-21, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
ViGenCell 308080 | +19.0% | 2,940 | ★ |
curacle 365270 | +10.0% | 8,600 | |
Chabiotech 085660 | +6.5% | 12,140 | |
Qurient 115180 | +5.9% | 5,950 | |
OSCOTECInc 039200 | +3.5% | 26,500 | |
CG Invites 083790 | +3.4% | 2,315 | |
Dong-a ST 170900 | +2.6% | 51,000 | |
NeoImmuneTech 950220 | +2.0% | 1,198 | |
ISU Abxis 086890 | +1.8% | 4,990 | |
Ahn-gook Pharmaceutical 001540 | +1.5% | 6,600 |
5. Stem Cells (recurred after 71 days)
- Episode: started 2025-02-21, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
ENCell 456070 | +14.4% | 20,700 | ★ |
Chabiotech 085660 | +6.5% | 12,140 | |
Xcell Therapeutics 373110 | +6.3% | 5,150 | |
Pharmicell 005690 | +4.3% | 11,300 | |
DongKoo Bio & Pharma 006620 | +2.8% | 5,040 | |
Medipost 078160 | +2.1% | 9,360 | |
Anterogen 065660 | +1.2% | 18,340 | |
Macrogen 038290 | +1.0% | 15,830 | |
Jeil Pharmaceutical 271980 | +0.7% | 11,300 |
Related news
- 질병청 “작년 연구용 줄기세포 제공 133건… 최근 5년대비 1.8배↑” — 서울경제 (Korean)
- 국가줄기세포 분양 5년새 2배↑…“희귀질환 치료 개발 기대” — 아시아경제 (Korean)
- 국가줄기세포은행 “작년 줄기세포 분양 133건, 최근 5년 대비 1.8배↑” — 머니투데이 (Korean)
6. Steel (Small & Mid Cap) (recurred after 2 days)
- Episode: started 2025-02-21, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
Moonbae Steel 008420 | +8.2% | 2,435 | ★ |
Nexteel 092790 | +5.4% | 9,880 | |
TCC Steel 002710 | +3.8% | 28,750 | |
Hyundai BNG Steel 004560 | +3.4% | 13,460 | |
SK oceanplant 100090 | +3.3% | 15,160 | |
Keum Kang Steel 053260 | +3.3% | 4,085 | |
Ajusteel 139990 | +3.3% | 4,080 | |
KBI Dong Yang Steel Pipe 008970 | +3.0% | 1,243 | |
dhSteel 021040 | +2.9% | 938 | |
DaeChang Steel 140520 | +2.7% | 2,070 |
7. Car Majors (recurred after 2 days)
- Episode: started 2025-02-21, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
Hanon Systems 018880 | +2.4% | 4,505 | ★ |
Hyundai Wia 011210 | +2.3% | 42,800 | |
KG Mobility 003620 | +1.6% | 3,865 | |
Hyundai Motor 005380 | +1.5% | 206,000 | |
Kia 000270 | +0.1% | 94,600 |
Closing Thoughts
Steel Majors is the only theme on a multi-day streak, now at 3 days since Feb 19, led by Posco Steeleon at 21.41%. Steel (Small & Mid Cap) also rose, with an average change of 3.93%.
Stem Cells returned after 71 days, alongside Feb 20 news of 133 research stem cell supplies. Car Majors trailed with an average change of 1.57%, the weakest of the session.